🔴 GH Research is trading 5% down today with sector weakness the likeliest context

GH Research is trading at $20.00, down 5.03%, with biotech-sector weakness the likeliest context.

• No clear GH Research-specific announcement or catalyst surfaced for October 8; a search result reporting a 5.7% rise appears to describe a different move and does not explain this decline.
• Biotech shares are under pressure, with the XBI down 2.04% during the regular session. Broader markets are also lower amid geopolitical and inflation concerns.